CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2019; 40(S 01): S33-S37
DOI: 10.4103/ijmpo.ijmpo_185_17
Original Article

Clinicopathological Presentation of Cervical Cancer in Bhopal

Rubal Jain
Department of Pathology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Rajendra Kumar Nigam
Department of Pathology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Reeni Malik
Department of Pathology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
,
Pramila Jain
Department of Pathology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Aim: To study the clinicopathological spectrum of cervical cancers in tertiary care center to assess scenario in Central India. Materials and Methods: Retrospective study in the Department of Pathology in our institution to evaluate cases of cervical cancers from January 2014 to August 2015. Histopathological diagnosis was correlated with age, symptoms, gravida, Federation of Gynecology and Obstetrics staging, and other relevant clinical details wherever deemed necessary. The biostatical analysis was performed for quantitative data student’s t-test was applied. P value was considered statistically significant if P < 0.05. Results: A total of 180 cases were of neoplasia cervix. Majority of cases were squamous cell carcinoma type, i.e., 96.6% (174 cases) followed by adenocarcinoma constituting only 2.8% (5 cases) with a mean age of 50.7 years and average gravida of 3.78. Majority of cases (50.01%) complained of postmenopausal bleeding followed by abnormal spotting (26.67%) and lower abdominal pain (7.78%). The most common presentation was in Stage IIB with 45.56% (82) cases. Conclusion: Histomorphology remains the mainstay of diagnosis of cervical cancers. In low compliance settings such as ours, colposcopy-guided biopsy is the preferred course of management, especially in elderly females to be definite to rule out or diagnose neoplasia. National level cervical cancer program is immediate need of the hour and should include human papilloma virus vaccine, awareness, and screening programs as well as treatment assistance for low socioeconomic strata.



Publication History

Article published online:
24 May 2021

© 2019. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Incidence/Mortality Data. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No 11. Lyon, France: International Agency for Research on Cancer; 2013
  • 2 Kitchener HC, Castle PE, Cox JT. Chapter 7: Achievements and limitations of cervical cytology screening. Vaccine 2006; 24 (03) Suppl S3/63-70
  • 3 Arrossi S, Matos E, Zengarini N, Roth B, Sankaranayananan R, Parkin M. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. Gynecol Oncol 2007; 105: 335-40
  • 4 Satija A. Cervical cancer in India. South Asia centre for chronic disease. Available from: http://sancd.org/uploads/pdf/cervical_ cancer.pdf. [Last accessed on 2014 Feb 16].
  • 5 Yeole BB, Kumar AV, Kurkure A, Sunny L. Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev 2004; 5: 308-15
  • 6 Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S. et al. Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India, JNCI Journal of the National Cancer Institute 2014;106(3). DOI: 10.1093/jnci/dju009.
  • 7 Mostafa MG, Srivannaboon S, Rachanawutanon M. Accuracy of cytological findings in abnormal cervical smears by cytohistologic comparison. Indian J Pathol Microbiol 2000; 43: 23-9
  • 8 Olu-Eddo AN, Ekanem VJ, Umannah I, Onakevhor J. A 20 year histopathological study of cancer of the cervix in Nigerians. Nig Q J Hosp Med 2011; 21: 149-53
  • 9 Okoye CA. Histopathological pattern of cervical cancer in Benin City, Nigeria. J Med Investig Pract 2014; 9: 147-50
  • 10 Abudu EK, Banjo AA, Izegbu MC, Agboola AO, Anunobi CC, Jagun OE. Histopathological pattern of carcinoma of cervix in Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria. NQJHM 2006; 16: 80-4
  • 11 Pathak TB, Pun CB, Shrestha S, Bastola S, Bhatta R. Incidence, trends and histopathological pattern of cervical malignancies at BP koirala memorial cancer hospital Nepal. J Pathol Nepal 2013; 3: 386-9
  • 12 Ikechebelu JI, Onyiaorah IV, Ugboaja JO, Anyiam DC, Eleje GU. Clinicopathological analysis of cervical cancer seen in a tertiary health facility in Nnewi, South-East Nigeria. J Obstet Gynaecol 2010; 30: 299-301
  • 13 Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: A 35-year population-based analysis. J Womens Health (Larchmt) 2012; 21: 1031-7
  • 14 Adeniji KA. Analysis of the histopathological pattern of carcinoma of the cervix in Ilorin, Nigeria. Niger J Med 2001; 10: 165-8
  • 15 WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer. (a) Human Papillomavirus and Related Cancers in India. Summary Report; 2009. Available from: http://www.who.int/hpvcentre/en/. [Last accessed on 2015 Nov 25].
  • 16 Jeebun N, Agnihotri S, Manraj S, Purwar B. Study of Cervical Cancers in Mauritius Over a Twelve Years Period (1989-2000) and Role of Cervical Screening. The Internet Journal of Oncology 2005:3(2).
  • 17 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
  • 18 Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Report on a workshop of the UICC project on evaluation of screening for cancer. Int J Cancer 1990; 46: 761-9
  • 19 Miller AB. Cervical Cancer Screening Programs: Managerial Guidelines. Geneva: World Health Organization; 1992
  • 20 Bishop A, Sherris J, Tsu VD, Kilbourne-Brook M. Cervical dysplasia treatment: Key issues for developing countries. Bull Pan Am Health Organ 1996; 30: 378-86
  • 21 Kaku M, Mathew A, Rajan B. Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pac J Cancer Prev 2008; 9: 589-94
  • 22 Bosch FX, de Sanjosé S. Chapter 1: Human papillomavirus and cervical cancer – Burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13
  • 23 Centers for Disease Control and Prevention. (c). Sexually Transmitted Diseases, Genital HPV Infection – CDC Fact Sheet. Available from: http://www.cdc.gov/STD/HPV/STDFact-HPV.htm. [Last accessed on 2009 Dec 25].
  • 24 Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I. et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004; 108: 329-33
  • 25 Soares GR, Vieira Rda R, Pellizzer EP, Miyahara GI. Indications for the HPV vaccine in adolescents: a review of the literature. J Infect Public Health 2015; 8: 105-16 DOI: 10.1016/j.jiph.2014.08.011.